Cannara Biotech Inc. (TSXV:LOVE)

Canada flag Canada · Delayed Price · Currency is CAD
1.910
0.00 (0.00%)
Aug 13, 2025, 3:59 PM EDT
193.85%
Market Cap 174.64M
Revenue (ttm) 101.87M
Net Income (ttm) 15.52M
Shares Out 91.43M
EPS (ttm) 0.17
PE Ratio 11.25
Forward PE 19.10
Dividend n/a
Ex-Dividend Date n/a
Volume 31,132
Average Volume 112,756
Open 1.910
Previous Close 1.910
Day's Range 1.890 - 1.910
52-Week Range 0.570 - 1.990
Beta 0.26
RSI 61.60
Earnings Date Jul 18, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. [Read more]

Sector Healthcare
Founded 2017
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol LOVE
Full Company Profile

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.

Financial Statements

News

There is no news available yet.